Episode
Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes
- Podcast
- Cell & Gene: The Podcast
- Published
- Jan 29, 2026
- Duration seconds
- 1803
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/building-safer-crispr-medicines-for-cvd-with-scribe-therapeutics-benjamin-oakes/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/cell-gene-the-podcast-4048431/building-safer-crispr-medicines-for-cvd-with-scribe-therapeutics-benjamin-oakes.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
We love to hear from our listeners. Send us a message. In episode 121 of Cell & Gene: The Podcast, Host Erin Harris talks to Scribe Therapeutics' CEO and Co-Founder Benjamin Oakes about building next‑generation CRISPR and epigenetic editing tools to move genetic medicine beyond rare disease into common cardiometabolic indications. Oakes shares Scribe’s engineered CasX platform and epigenetic silencers, preclinical data from its various programs, and why exquisite specificity and low-dose ...